Clinical Trial: A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07067138) titled 'A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)' on July 12.

Brief Summary: Background:

Breast cancer is the most common cancer in US women. There are different types of breast cancers; some are aggressive and difficult to treat. Researchers want to know if an algorithm (ENLIGHT) can help choose approved drugs that will treat these cancers more effectively.

Objective:

To test whether ENLIGHT can find better treatments for aggressive breast cancers.

Eligibility:

People aged 18 years and older with triple-negative or endocrine therapy resistant breast...